A program to lead and conduct clinical trials for gastrointestinal cancers.
Official title: Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application
Funded at University of Utah · NIH-11251531 · Data updated 2026-11-12
This study is all about finding better treatments for gastrointestinal cancers, and it invites patients to join exciting clinical trials at the Huntsman Cancer Institute, where expert doctors are working together to discover new therapies that could help improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | December 24, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $301,967 |
| NIH project number | 3UG1CA233178-06S1 |
| Project ID | NIH-11251531 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with gastrointestinal cancers who are seeking new treatment options.
✕Less likely to help
Patients with cancers outside the gastrointestinal tract or those who are not eligible for clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing the development and execution of clinical trials specifically for gastrointestinal cancers at the Huntsman Cancer Institute. As a National Cancer Institute Network Lead Academic Participating Site, the institute collaborates with various oncology groups to ensure robust patient enrollment and trial participation. The program is led by experienced oncologists who specialize in gastrointestinal and neuroendocrine cancers, aiming to improve treatment options through innovative clinical trials. Patients may have the opportunity to participate in cutting-edge trials that could lead to new therapies.
Why it matters
Potential benefit: If successful, this research could provide patients with access to novel treatments for gastrointestinal cancers that are currently lacking effective therapies.
How similar studies have gone: Previous research has shown success in similar collaborative approaches to clinical trials, indicating a strong potential for impactful outcomes.
Where this research is happening
-
University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Soares, Heloisa Prado — University of Utah
- Study coordinator: Soares, Heloisa Prado
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.